US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc. Warrant

0.0364

-0.0020-5.33%

Volume:11.23K

Turnover:441.81

Market Cap:717.26K

PE:-0.02

High:0.0400

Open:0.0400

Low:0.0364

Close:0.0385

52wk High:0.1751

52wk Low:0.0293

Shares:19.71M

Float Shares:19.71M

Volume Ratio:1.08

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3221

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NRX Pharmaceuticals Inc. Warrant

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.salbergco.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRXPW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NRXPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXPW\",,,,,undefined,":{"symbol":"NRXPW","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc. Warrant","latestPrice":0.0364,"timestamp":1771880400000,"preClose":0.03845,"halted":0,"volume":11228,"delay":0,"changeRate":-0.05331599479843944,"floatShares":19705079,"shares":19705079,"eps":-2.3221,"marketStatus":"Post-Mkt","change":-0.00205,"latestTime":"02-23 16:46:52 EST","open":0.04,"high":0.04,"low":0.0364,"amount":441.811,"amplitude":0.093628,"askPrice":0.0452,"askSize":100,"bidPrice":0.0311,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.3221,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771894800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.03845,"volumeRatio":1.07891},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXPW\",,,,,undefined,":{"symbol":"NRXPW","floatShares":19705079,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.07891,"shares":19705079,"dividePrice":0,"high":0.04,"amplitude":0.093628,"preClose":0.03845,"low":0.0364,"week52Low":0.0293,"pbRate":"--","week52High":0.1751,"institutionHeld":0,"latestPrice":0.0364,"eps":-2.3221,"divideRate":0,"volume":11228,"delay":0,"ttmEps":-2.3221,"open":0.04,"prevYearClose":0.0708,"prevWeekClose":0.0384,"prevMonthClose":0.0592,"prevQuarterClose":0.0708,"fiveDayClose":0.0346,"twentyDayClose":0.0658,"sixtyDayClose":0.0758},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRXPW\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"NRXPW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755504000000,"name":null,"time":"Pre-Market","dateTimestamp":1755489600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRXPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRXPW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.salbergco.com","stockEarnings":[{"period":"1week","weight":0.1116},{"period":"1month","weight":-0.4174},{"period":"3month","weight":-0.4085},{"period":"6month","weight":-0.6036},{"period":"1year","weight":-0.7152},{"period":"ytd","weight":-0.4569}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.077298},{"month":2,"riseRate":0.2,"avgChangeRate":-0.130288},{"month":3,"riseRate":0.25,"avgChangeRate":-0.185523},{"month":4,"riseRate":0,"avgChangeRate":-0.2226},{"month":5,"riseRate":0.5,"avgChangeRate":-0.022357},{"month":6,"riseRate":0.2,"avgChangeRate":-0.201178},{"month":7,"riseRate":0.6,"avgChangeRate":0.319712},{"month":8,"riseRate":0.6,"avgChangeRate":-0.029431},{"month":9,"riseRate":0.2,"avgChangeRate":-0.108415},{"month":10,"riseRate":0.4,"avgChangeRate":0.232332},{"month":11,"riseRate":0.2,"avgChangeRate":-0.066365},{"month":12,"riseRate":0.4,"avgChangeRate":0.412683}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc. Warrant","nameEN":"NRX Pharmaceuticals Inc. Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NRXPW\",market:\"US\",,,undefined,":null}}